Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1071-1079

  Dobrucki, Lawrence W ^a   Tsutsumi, Yoshiaki ^b   Kalinowski, Leszek ^a,c   Dean, Jarrod ^b   Gavin, Mary ^b   Sen, Sabyasachi ^b   Mendizabal, Marivi ^d   Sinusas, Albert J ^a   Aikawa, Ryuichi ^b,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d GE HEALTHCARE   (United Kingdom)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

AAV; Angiogenesis; IGF 1; MicroSPECT CT; Molecular imaging; Myocardial infarction

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA GALACTOSIDASE; CD51 ANTIGEN; NC 100692; PARVOVIRUS VECTOR; SOMATOMEDIN C; TECHNETIUM 99M; THALLIUM CHLORIDE TL 201; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL STRAIN; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG RETENTION; EMBRYO; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; ISOTOPE LABELING; LONG TERM EXPOSURE; MALE; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPRAGUE DAWLEY RAT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DEPENDOVIRUS; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTEGRIN ALPHAV; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

ADENO-ASSOCIATED VIRUS; ANIMALIA; RATTUS;

EID: 77952670495     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.10.008     Document Type: Article

References (36)

1. Liu J.L., Yakar S., LeRoith D. Mice deficient in liver production of insulin-like growth factor I display sexual dimorphism in growth hormone-stimulated postnatal growth. Endocrinology 2000, 141(22):4436-4441.
2. Khan A.S., Sane D.C., Wannenburg T., Sonntag W.E. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res 2002, 54(1):25-35.
3. Delafontaine P., Song Y.H., Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004, 24(3):435-444.
4. Li Q., Li B., Wang X., Leri A., Jana K.P., Liu Y., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997, 100(8):1991-1999.
5. Welch S., Plank D., Witt S., Glascock B., Schaefer E., Chimenti S., et al. Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res 2002, 90(6):641-648.
6. Torella D., Rota M., Nurzynska D., Musso E., Monsen A., Shiraishi I., et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004, 94(4):514-524.
7. Schulze P.C., Fang J., Kassik K.A., Gannon J., Cupesi M., MacGillivray C., et al. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res 2005, 97(5):418-426.
8. Su E.J., Cioffi C.L., Stefansson S., Mittereder N., Garay M., Hreniuk D., et al. Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization. Am J Physiol Heart Circ Physiol 2003, 284(4):H1429-1440.
9. Lopez-Lopez C., LeRoith D., Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci U S A 2004 Jun 29, 101(26):9833-9838. 2004.
10. Rabinovsky E.D., Draghia-Akli R. Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Mol Ther 2004, 9(1):45-46.
11. Jabri N., Schalch D.S., Schwartz S.L., Fischer J.S., Kipnes M.S., Radnik B.J., et al. Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patient. Diabetes 1994, 43(3):369-374.
12. Su H., Lu R., Kan Y.W. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci U S A 2000, 97(25):13801-13806.
13. Melo L.G., Agrawal R., Zhang L., Rezvani M., Mangi A.A., Ehsan A., et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002, 105(5):602-607.
14. Hoshijima M., Ikeda Y., Iwanaga Y., Minamisawa S., Date M.O., Gu Y., et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 2002, 8(8):864-871.
15. Snyder R.O., Spratt S.K., Lagarde C., Bohl D., Kaspar B., Sloan B., et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 1997, 8(16):1891-1900.
16. Fisher K.J., Jooss K., Alston J., Yang Y., Haecker S.E., High K., et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997, 3(3):306-312.
17. Aikawa R., Huggins G.S., Snyder R.O. Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction. J Biol Chem 2002, 277(21):18979-18985.
18. Kusano K., Tsutsumi Y., Dean J., Gavin M., Ma H., Silver M., et al. Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction. J Mol Cell Cardiol 2007, 42:390-399.
19. 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia. Circulation 2005 Jun 21, 111(24):3255-3260.
20. Lindsey M.L., Escobar G.P., Dobrucki L.W., Goshorn D.K., Bouges S., Mingoia J.T., et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol 2006 Jan, 290(1):H232-239.
21. Kalinowski L., Dobrucki L.W., Meoli D.F., Dione D.P., Sadeghi M.M., Madri J.A., et al. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction. J Appl Physiol 2008 May, 104(5):1504-1512.
22. Meoli D.F., Sadeghi M.M., Krassilnikova S., Bourke B.N., Giordano F.J., Dione D.P., et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 2004 Jun, 113(12):1684-1691.
23. 99mTc-NC100692-a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation. Nucl Med Biol 2008 Apr, 35(3):365-375.
24. Iwakura A., Dean J., Hamada H., Eaton E., Qin G., Losordo D.W., et al. Use of recombinant adeno-associated viral vectors as a tool for labeling bone marrow cells. J Mol Cell Cardiol 2005, 38:799-802.
25. Losordo D.W., Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation 2004, 109(21):2487-2491.
26. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998, 98(25):2800-2804.
27. Horvath K.A., Doukas J., Lu C.Y., Belkind N., Greene R., Pierce G.F., et al. Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. Ann Thorac Surg 2002, 74(2):481-486.
28. Spyridopoulos I., Luedemann C., Chen D., Kearney M., Murohara T., Principe N., et al. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol. 2002, 22(6):901-906.
29. Dimmeler S., Zeiher A.M. Akt takes center stage in angiogenesis signaling. Circ Res. 2000 January 7, 86(1):4-5. 2000.
30. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103(5):634-637.
31. Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005, 115(2):326-338.
32. Takahashi A., Kureishi Y., Yang J., Luo Z., Guo K., Mukhopadhyay D., et al. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol 2002, 22(13):4803-4814.
33. Khan A.S., Lynch C.D., Sane D.C., Willingham M.C., Sonntag W.E. Growth hormone increases regional coronary blood flow and capillary density in aged rats. J Gerontol A Biol Sci Med Sci 2001, 56(8):B364-371.
34. Chao W., Matsui T., Novikov M.S., Tao J., Li L., Liu H., et al. Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J Gene Med 2003, 5(4):277-286.
35. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol 1999, 9(15):845-848.
36. Dobrucki L., Hua J., Bourke B., Sadeghi M., Cavaliere P., Mendizabal M., et al. Non-invasive imaging of hypoxia induced angiogenesis following hindlimb ischemia in mice. J Nucl Cardiol 2004, 11:372.